| Product description : |
Repaglinide Basic information
Product Name: Repaglinide
Synonyms: AG-EE-623;2-ETHOXY-4-[2-[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)BUTYL]AMINO]-2-OXOETHYL]-BENZOIC ACID;REPAGLINIDE;(S)-2-ETHOXY-4-(2-(3-METHYL-1-(2-(PIPERIDIN-1-YL)PHENYL)BUTYLAMINO)-2-OXOETHYL)BENZOIC ACID;(S)-(+)-2-ETHOXY-4-[N-[1-(2-PIPERIDINOPHENYL)-3-METHYL-1-BUTYL]AMINOCARBONYLMETHYL]BENZOIC ACID;NOVONORM;PRANDIN;ag-ee388zw
CAS: 135062-02-1
MF: C27H36N2O4
MW: 452.59
EINECS:
Product Categories: Pharmaceutical material and intermeidates;Active Pharmaceutical Ingredients;Chiral Reagents;Amino Acids 13C, 2H, 15N;Chemical Impurities;Impurities;Intermediates & Fine Chemicals;Pharmaceuticals;Amino Acids & Derivatives;Aromatics;Heterocycles;API;Pharmaceutical raw material;DTIC-DOME
Repaglinide Usage And Synthesis
Chemical Properties White to Off-White Solid
Usage Non-sulfonylurea oral hypoglycemic agent. Used as an antidiabetic
Usage The R-enantiomer showed only weak hypoglycemic activity. Repaglinide impurity
Usage antineoplastic
Usage A KIR6 (KATP) channel blocker
Biological Activity K ATP channel blocker that binds with high affinity for SUR1 when co-expressed with Kir6.2 (K d = 0.42 nM). Antidiabetic glucose regulator with hypoglycaemic effect in vivo . |
